Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D R Gretch

Showing results (31-40 of 66) with videos related to

Pageof 7
Sort By:
Journal of Virology|December 1, 1996
Elimination of hepatitis C virus RNA in infected human hepatocytes by adenovirus-mediated expression of ribozymesA Lieber, C Y He, S J Polyak, et al.
The Journal of Infectious Diseases|July 29, 2000
The protein kinase-interacting domain in the hepatitis C virus envelope glycoprotein-2 gene is highly conserved in genotype 1-infected patients treated with interferonS J Polyak, J B Nousbaum, A M Larson, et al.
Journal of Clinical Microbiology|February 1, 1993
Detection of hepatitis C virus RNA: comparison of one-stage polymerase chain reaction (PCR) with nested-set PCRD R Gretch, J J Wilson, R L Carithers, et al.
Journal of Virology|November 1, 1996
Tracking hepatitis C virus quasispecies major and minor variants in symptomatic and asymptomatic liver transplant recipientsD R Gretch, S J Polyak, J J Wilson, et al.
Clinical Chemistry|December 6, 2000
Diagnosis and monitoring of hepatic injury. I. Performance characteristics of laboratory testsD R Dufour, J A Lott, F S Nolte, et al.
Journal of Viral Hepatitis|June 10, 2000
Pretreatment symptoms and dosing regimen predict side-effects of interferon therapy for hepatitis CS J Cotler, C F Wartelle, A M Larson, et al.
Hepatology (Baltimore, Md.)|July 1, 1997
Dose-dependent acute clearance of hepatitis C genotype 1 virus with interferon alfaN P Lam, A U Neumann, D R Gretch, et al.
Clinical Chemistry|December 6, 2000
Diagnosis and monitoring of hepatic injury. II. Recommendations for use of laboratory tests in screening, diagnosis, and monitoringD R Dufour, J A Lott, F S Nolte, et al.
Journal of Virology|August 10, 1999
Effect of retreatment with interferon alone or interferon plus ribavirin on hepatitis C virus quasispecies diversification in nonresponder patients with chronic hepatitis CM Gerotto, D G Sullivan, S J Polyak, et al.
Journal of Clinical Gastroenterology|December 22, 1999
Relationship between iron concentration and hepatitis C virus RNA level in liver tissueS J Cotler, M J Emond, D R Gretch, et al.
Pageof 7

Showing results (31-40 of 66) with videos related to

Sort By:
Pageof 7
Journal of Virology|December 1, 1996
Elimination of hepatitis C virus RNA in infected human hepatocytes by adenovirus-mediated expression of ribozymesA Lieber, C Y He, S J Polyak, et al.
The Journal of Infectious Diseases|July 29, 2000
The protein kinase-interacting domain in the hepatitis C virus envelope glycoprotein-2 gene is highly conserved in genotype 1-infected patients treated with interferonS J Polyak, J B Nousbaum, A M Larson, et al.
Journal of Clinical Microbiology|February 1, 1993
Detection of hepatitis C virus RNA: comparison of one-stage polymerase chain reaction (PCR) with nested-set PCRD R Gretch, J J Wilson, R L Carithers, et al.
Journal of Virology|November 1, 1996
Tracking hepatitis C virus quasispecies major and minor variants in symptomatic and asymptomatic liver transplant recipientsD R Gretch, S J Polyak, J J Wilson, et al.
Clinical Chemistry|December 6, 2000
Diagnosis and monitoring of hepatic injury. I. Performance characteristics of laboratory testsD R Dufour, J A Lott, F S Nolte, et al.
Journal of Viral Hepatitis|June 10, 2000
Pretreatment symptoms and dosing regimen predict side-effects of interferon therapy for hepatitis CS J Cotler, C F Wartelle, A M Larson, et al.
Hepatology (Baltimore, Md.)|July 1, 1997
Dose-dependent acute clearance of hepatitis C genotype 1 virus with interferon alfaN P Lam, A U Neumann, D R Gretch, et al.
Clinical Chemistry|December 6, 2000
Diagnosis and monitoring of hepatic injury. II. Recommendations for use of laboratory tests in screening, diagnosis, and monitoringD R Dufour, J A Lott, F S Nolte, et al.
Journal of Virology|August 10, 1999
Effect of retreatment with interferon alone or interferon plus ribavirin on hepatitis C virus quasispecies diversification in nonresponder patients with chronic hepatitis CM Gerotto, D G Sullivan, S J Polyak, et al.
Journal of Clinical Gastroenterology|December 22, 1999
Relationship between iron concentration and hepatitis C virus RNA level in liver tissueS J Cotler, M J Emond, D R Gretch, et al.
Pageof 7